Over the past year there were no insider purchases at Soleno Therapeutics Inc. Two insiders sold roughly $429,000 instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Manning Meredith | Executive Officer | Sell | 558 | $31.72 | $18K | SEC |
| Mar 31, 2026 | Manning Meredith | Executive Officer | Sell | 2,100 | $31.04 | $65K | SEC |
| Mar 31, 2026 | Manning Meredith | Executive Officer | Sell | 4,864 | $30.04 | $146K | SEC |
| Mar 31, 2026 | Huang Michael F. | Officer | Sell | 4,256 | $30.04 | $128K | SEC |
| Mar 31, 2026 | Huang Michael F. | Officer | Sell | 488 | $31.72 | $15K | SEC |
| Mar 31, 2026 | Huang Michael F. | Officer | Sell | 1,838 | $31.04 | $57K | SEC |
| Jul 3, 2025 | Hirano Patricia C | Officer | Sell | 3,830 | $82.76 | $317K | SEC |
| Jun 26, 2025 | Hirano Patricia C | Officer | Sell | 266 | $84.25 | $22K | SEC |
| Apr 2, 2025 | Hirano Patricia C | Officer | Sell | 3,782 | $70.11 | $265K | SEC |
| Mar 31, 2025 | Yen Kristen | Officer | Sell | 2,881 | $66.79 | $192K | SEC |
| Mar 31, 2025 | Yen Kristen | Officer | Sell | 3,990 | $69.84 | $279K | SEC |
| Mar 31, 2025 | Yen Kristen | Officer | Sell | 411 | $70.73 | $29K | SEC |
| Mar 31, 2025 | Yen Kristen | Officer | Sell | 50,156 | $66.00 | $3.3M | SEC |
| Mar 31, 2025 | Yen Kristen | Officer | Sell | 5,239 | $67.70 | $355K | SEC |
| Mar 31, 2025 | Manning Meredith | Executive Officer | Sell | 34 | $72.64 | $2K | SEC |
In the last 12 months Soleno Therapeutics Inc insiders made open-market purchases worth about $0 and sales worth about $429,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SLNO was filed on 2026-03-31.
No congressional trades in SLNO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).